MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinson’s"

  • 2022 International Congress

    Genetics Of Parkinson’s in India – Young Onset Parkinson’s Disease (GOPI-YOPD) : Genetics of Juvenile, Young and Early Onset Parkinson’s Disease

    P. Kukkle, V. Goyal, T. Geetha, R. Menon, R. Kandadai, U. Mahadevia, H. Kumar, R. Borgohain, A. Mukherjee, P. Wadia, R. Yadav, S. Desai, N. Kumar, S. Nair, S. Murugan, A. Biswas, P. Pal, M. Oliver, S. Sundaram, M. Deshmukh, A. Bassi, C. Sandeep, N. Mandloi, A. Kayalvizhi, U. Muthane, S. Das, S. Seshagiri, R. Gupta, V. Ramprasad (Bangalore, India)

    Objective: To determine the genetic and demographic patterns of juvenile-onset (JOPD, <20 years), young-onset (YOPD, 20-40 years), and early onset (EOPD, 40-50 years) Parkinson's disease…
  • 2022 International Congress

    Clinical characteristics in de-novo PD patients with reversible vs. progressive cognitive dysfunction during long-term follow-up

    K. Kawabata, A. Djamshidian-Tehrani, K. Seppi, W. Poewe (Innsbruck, Austria)

    Objective: To compare clinical and imaging features in de-novo Parkinson’s disease (PD) with stable, remitting, and non-remitting cognition over 5 years follow-up. Background: Mild cognitive…
  • 2022 International Congress

    The Lion’s tail family: A Bavarian multiplex pedigree with pathologically confirmed multiple system atrophy and Parkinson’s disease with dementia

    A. Fanciulli, F. Leys, F. Lehner, V. Sidoroff, V. Ruf, C. Raccagni, P. Mahlknecht, D. Kuipers, W. van Ijcken, H. Stockner, T. Musacchio, J. Volkmann, C. Monoranu, I. Stankovic, G. Breedveld, F. Ferraro, C. Fevga, O. Windl, J. Herms, S. Kiechl, W. Poewe, K. Seppi, N. Stefanova, S. Scholz, V. Bonifati, G. Wenning (Innsbruck, Austria)

    Objective: To characterize a North-Bavarian (Lion’s tail region) six-generation pedigree, including neuropathologically confirmed multiple system atrophy and Parkinson’s disease with dementia. Background: Multiple system atrophy…
  • 2022 International Congress

    Case reports of first experiences worldwide with novel continuous oral levodopa dental pump in Parkinson’s Disease Patients

    D. Mcintyre, O. Terwindt, L. Pavelka, G. Schilling, A. Znati, L. Skhiri, M. Gantenbein, E. Heller, A. Heller, J. Kennedy, J. Harmon, C. Kamp, M. Torti, CW. Olanow, R. Krueger (Strassen, Luxembourg)

    Objective: To assess the safety, tolerability, and pharmacokinetics (PK) of a novel continuous levodopa-carbidopa oral pump (LCOP) delivery system in patients with early PD. Background:…
  • 2022 International Congress

    The relationship between sleep and Parkinson’s disease progression: A Mendelian Randomization study

    E. Matar, M. Mahjoub (Sydney, Australia)

    Objective: The objective of the study was to determine the causality between sleep disorders and progression of motor and cognitive endpoints of Parkinson’s disease. Background:…
  • 2022 International Congress

    Preliminary results on the cognitive profile in prodromal Parkinson’s disease – a prospective study

    L. Pauly, M. Hansen, C. Pauly, A. Leist, R. Krüger (Strassen, Luxembourg)

    Objective: This study aims to investigate the cognitive profile in people with REM-sleep behavior disorder (RBD) and hyposmia, in a prodromal Parkinson’s disease (PD) cohort.…
  • 2022 International Congress

    Impact of DBS on cognitive functions in Parkinson’s disease in 1 year follow-up

    A. Martinkovičová, Z. Košutzká, M. Pápayová, I. Straka, M. Kľoc, P. Valkovič (Bratislava, Slovakia)

    Objective: The aim of our study was to compare performance in neuropsychology tests in patients with Parkinson’s disease (PD) with implanted electrodes of Deep Brain…
  • 2022 International Congress

    The Magnetic Resonance Parkinsonism Index as a diagnostic marker for differentiating PSP from IPD

    L. Haupt, S. Kannenberg, J. Caspers, C. Hartmann, A. Schnitzler (Düsseldorf, Germany)

    Objective: The Magnetic Resonance Parkinsonism Index (MRPI) has been proposed as an enhancement of the Midbrain to Pons Ratio (MTPR) as a diagnostic tool for…
  • 2022 International Congress

    Efficacy of Apomorphine Sublingual Film Versus Subcutaneous Apomorphine for the Treatment of OFF Episodes in Parkinson’s Disease

    F. Stocchi, O. Rascol, W. Poewe, R. Chaudhuri, J. Kassubek, L. Lopez Manzanares, V. Leta, I. Zhang, A. Bowling, S. Wu, E. Pappert (Rome, Italy)

    Objective: Evaluate efficacy and patient satisfaction associated with apomorphine sublingual film (SL-APO) vs subcutaneous apomorphine (SC-APO) for the treatment of OFF episodes in patients with…
  • 2022 International Congress

    Influence of alcohol consumption on cognitive decline in Parkinson disease.

    E. Ruiz-Fernández, J. Marín-Lahoz, J. Pagonabarraga, A. Horta-Barba, S. Martínez-Horta, H. Bejr-Kasem, I. Aracil-Bolaños, A. Campolongo, J. Kulisevsky (Zaragoza, Spain)

    Objective: To assess whether alcohol consumption (AC) is independently associated with cognitive decline (CD) in PD. Background: AC is linked to dementia and neurological damage…
  • « Previous Page
  • 1
  • …
  • 217
  • 218
  • 219
  • 220
  • 221
  • …
  • 338
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • An atypical and interesting feature of Parkinson´s disease
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley